General gene mechanism between Parkison and malignant tumors

From Washington, US scientists have discovered an association between Parkison's disease and malignant tumors.

The fact that a person has simultaneously contracted Parkison's disease and malignant tumors has been considered in many studies. However, the work of researchers at Harvard Medical School this time is the first to show a common genetic mechanism between Parkison's disease and malignant tumors.

Scientists conducted research and analysis of data on nearly 132,000 people without Parkison's disease. After 14-20 years, 543 people had this disease.

Checking health information of relatives of these subjects (parents, siblings), scientists discovered the risk of Parkison disease in people whose relatives have malignant twice as high compared to ordinary people. Since then, researchers have drawn conclusions between Parkison's disease and malignant tumors that have common genetic factors.

Parkison is a disease in which the central nervous system rapidly deteriorates causing muscles to vibrate and weaken. The reason is that the ability to produce dopamine agonists in brain cells is reduced. There is no effective cure for this disease.

Whereas, u is an abnormal proliferative tissue, creating an excess of cells that can be benign or malignant. However, unlike benign tumors, malignant tumors include highly variable, invasive cells that change into the realm of normal cells.